coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Folkestone Hythe & Rural PCN, Folkestone and Hythe · Health Inequalities Profile

    PCN U80502 · NHS Kent and Medway Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    50,158

    Registered population

    55.3% aged 18–64

    27.6%

    Aged 65+

    ICB 19.9% · England 17.9%

    8.3%

    Ethnic minority (non-White)

    4.5% Asian · England 9.6%

    7.8%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~3,324

    Core20 residents (est.)

    Resident basis; registered basis ~4,116 · see page 3

    9,439

    Hypertension register

    +3.14% in 3 yrs · England +5.60%

    508

    SMI register

    36% of Folkestone and Hythe's

    1,117

    COPD register

    Reviews +4.79% in 3 yrs

    Forecast to 2030

    10,384

    Hypertension patients, 2030

    +945 on today

    63.1%

    QRISK ≥20% on statins, 2030

    +3.00pp over 3 yrs

    7.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    56.6%
    High-risk lipid therapy and diabetes statins lag.

    Lipid-lowering therapy for QRISK >= 20% is 56.6% (England 63.6%), while statin treatment in diabetes fell 1.7% to 69.2% (England +2.1%, 73.2%).

    71.7%
    Hypertension control and COPD reviews exceed England.

    Hypertension treatment to target is 71.7% (England 70.3%, ICB 67.7%), and annual COPD reviews rose +4.8% to 77.0% (England +2.8%, 76.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    With 27.6% aged 65+, an older population may increase PCN complex care demand

    Of 50,158 registered patients, 27.6% (13,842) are aged 65+, exceeding Folkestone and Hythe (25.7%), the ICB (19.9%) and England (17.9%). Working-age patients (18–64) represent 55.3% (LAD 56.9%, ICB 59.5%, England 62.7%) and children (0–17) 17.1% (LAD 17.4%, ICB 20.7%, England 19.6%). Based on resident Census estimates rather than registered ethnicity, White residents represent 91.7% across the PCN (LAD 92.6%, ICB 88.6%, England 81.1%), and the PCN ethnic minority share is 8.3%. Asian / Asian British residents comprise 4.5% across the PCN. At White House Surgery, Asian / Asian British residents account for 10.1%.

    Age profile

    0–1717.1%
    18–6455.3%
    65+27.6%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White91.7%
    Asian4.5%
    Mixed2.0%
    Other1.1%
    Black0.7%

    Older people · falls rows are Folkestone and Hythe local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Folkestone & Hythe LA)1,6992,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.9%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.1%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Folkestone & Hythe LA)8569819552024/25
    Falls deaths, all ages, per 100,000 (Folkestone & Hythe LA)16.014.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 7.8% overall but reaches 77.6% at Harbour Medical Practice

    The PCN Core20 share is 7.8%, below Folkestone and Hythe (21.7%), the ICB (17.1%) and England (21.0%). However, deprivation is sharply polarised across practices: Harbour Medical Practice has a 77.6% Core20 share (2,580 estimated patients), whereas White House Surgery has 0.0%. Practice-level registered estimates sum to 4,116 patients, whereas resident decile 1 and 2 counts total 3,324. This discrepancy between registered and resident bases requires local reconciliation to avoid misdirecting neighbourhood outreach capacity.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Harbour Medical77.6% · 2,580 patients
    Oaklands9.2% · 1,137 patients
    Sun Lane7.5% · 399 patients
    White House0.0% · 0 patients
    Hawkinge And0.0% · 0 patients
    Church Road0.0% · 0 patients
    New Lyminge0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    508

    SMI register

    1.00% recorded prevalence

    321

    Learning disability register

    0.63% recorded prevalence

    46

    Care homes, 984 beds

    In the PCN catchment

    10.2%

    Provide unpaid care

    Folkestone and Hythe, Census 2021

    The PCN records 508 severe mental illness patients (1.0%; LAD 1.2%, ICB 0.9%, England 1.0%) and 321 with learning disabilities (0.6%; LAD 0.9%, ICB 0.6%, England 0.6%), with 46 catchment care homes (984 beds). Borough data shows 21 rough sleepers and a 10.2% carer rate.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.0% (508 patients). On the SMI register, annual blood pressure checks reached 76.8% (England 83.4%) and BMI recording reached 76.5% (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,439

    Hypertension register

    +3.14%

    Register growth, 3 yrs

    Folkestone and Hythe +5.18% · England +5.60%

    −0.09pp

    BP control, under 80

    ≤140/90 · +2.14pp aged 80+

    +945

    More patients by 2030

    Forecast 10,384 (19.79%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.6% (9,439 patients), above England (15.2%) and NHS Kent and Medway ICB (16.2%), with practice prevalence ranging from 13.6% at White House Surgery to 23.0% at Church Road. Although 71.7% of patients are treated to target (England 70.3%), three-year change in blood pressure control for patients under 80 fell 0.1% over 2023 to 2025 (England +3.2%; Folkestone and Hythe +6.3%).

    Lipids and statins

    Recorded lipid-lowering therapy for QRISK ≥ 20% is 56.6%, trailing England (63.6%) and NHS Kent and Medway ICB (61.4%), while statin treatment in diabetes aged 40+ without CVD fell 1.7% over 2023 to 2025 to 69.2% (England +2.1%, 73.2%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202697,437£2.20£1.90£1.86£214,361
    Cardiovascular (all), 2025134,620£4.28£3.57£3.33£576,174

    In 2026, lipid-regulating drugs averaged £2.20 per item across 97,437 items, exceeding England (£1.86), NHS Kent and Medway ICB (£1.90), and Folkestone and Hythe (£2.17), spending £33,129 more than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.34%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.79%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.2% (1,117 patients; England 1.9%) with 77.0% reviewed annually (England 76.4%), up +4.8% over 2023 to 2025 (England +2.8%). Recorded asthma prevalence is 6.6% (3,169 patients; England 6.6%), but annual reviews fell 2.3% over 2023 to 2025 to 63.2% (England +4.4%, 65.7%), leaving an unreviewed scale indicator of 1,165 patients. Second-hand smoke status recording in asthma patients aged 6-19 is 73.8% (England 78.8%).

    Cancer register and children's immunisation

    Cancer register prevalence is 5.8% (2,952 patients; England 3.8%). In Q1 2025/26 childhood immunisations, age-5 MMR dose 1 reached 95.7% but dose 2 is 90.4% (target 95.0%), a 5.3 pp dose difference. At White House Surgery, dose 2 is 81.1% against 94.6% for dose 1 (a 13.5 pp difference). Age-5 4-in-1 booster coverage is 86.1%, 8.9 pp below the 95.0% target.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.5%

    England 91.0%

    6-in-1 complete primary course at 24 months94.4%

    England 92.2%

    MMR dose 1 at 24 months91.7%

    England 88.3%

    MMR dose 2 at age 590.4%

    England 82.8%

    4-in-1 pre-school booster at age 586.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of staged ICB cancers were diagnosed at stage 1 or 2 (England 55.3%; 75.0% national ambition, 19.4 pp below standard), requiring 1,627 extra early-stage cases to reach target. ICB known-stage coverage was 63.6% (8,384 of 13,189 cancers; England 67.0%), reflecting wider-system pathways rather than PCN performance. PCN cancer prevalence is 5.8% (2,952 patients; England 3.8%). Breast screening coverage is 71.2% (England 69.9%; three-year change +10.9%, England +8.4%). Cervical screening in women aged 25 to 49 fell 3.6% over 2023 to 2025 (England -1.0%) to 69.6% (England 66.8%), reaching 63.1% at Sun Lane and 65.6% at White House Surgery.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), East Kent Hospitals University NHS Foundation Trust achieved 70.0% on the 62-day referral to treatment standard (15.0 pp below the 85.0% standard), compared with 87.4% at Maidstone and Tunbridge Wells NHS Trust, 67.0% at East Sussex Healthcare NHS Trust, 75.9% across NHS Kent and Medway Integrated Care Board, and 71.2% in England. On the 28-day faster diagnosis standard, East Kent Hospitals achieved 71.3% (3.7 pp below the 75.0% standard; NHS Kent and Medway Integrated Care Board 76.8%, England 79.3%). These acute figures describe system pressures rather than PCN performance.

    Pathways within standard (%)East KentEast Sussex HealthcareMaidstone and Tunbridge WellsKent and Medway ICBEngland
    28-day faster diagnosis (75%)71.2884.2081.7876.7879.32
    31-day treatment (96%)96.6798.1998.3595.8492.50
    62-day referral to treatment (85%)70.0167.0487.4375.9371.16
    Diagnostic waits over 6 weeks (%)East KentEast Sussex HealthcareMaidstone and Tunbridge WellsEngland
    MRI47.586.480.9221.40
    CT37.450.480.519.92
    Echocardiography14.1721.942.5728.48
    Colonoscopy9.580.7419.8030.83
    Gastroscopy22.160.3124.0329.02
    All 15 DM01 tests48.385.276.4223.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In the Community Services Dataset for Jun 2026 (provisional), adults aged 65 and over accounted for 65.8% of community contacts among Folkestone and Hythe borough residents (138,250 of 210,170 contacts). Provider-level and PCN-level breakdowns were not captured. These borough-level contacts reflect wider community service use rather than PCN activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    Across practices in 2025/26, QOF vaccination and immunisation achievement varied by 53.7 pp, from 26.9% at White House Surgery to 80.6% at New Lyminge Surgery (England 55.2%). Overall QOF achievement was 75.3% at White House Surgery (England 92.5%), while Oaklands Health Centre reached 91.6%. Variation across practices remains unverified locally.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Church Road1250.094.8%77.7%95.6%
    New Lyminge1220.055.8%62.7%75.3%
    Hawkinge And Elham970.050.1%67.6%74.0%
    Sun Lane1107.556.1%73.8%72.0%
    Oaklands1249.249.2%61.4%71.9%
    White House1110.028.3%50.4%64.9%
    Harbour Medical10277.645.5%61.3%48.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNFolkestone and HytheAssetPCNFolkestone and Hythe
    Care homes (catchment)46 (984 beds)n/aSchools (catchment)71n/a
    Children's centres58Places of worship6078
    Libraries68Food banks (VCS)n/a1
    Day centres (VCS)n/a2Children and young people (VCS)n/a1
    Carers support groups (VCS)11Primary schools (LA maintained)1921
    Primary academies1115Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured annual asthma review recall

    Annual asthma reviews fell 2.3% over 2023 to 2025 to 63.2% (England +4.4%, 65.7%; Folkestone and Hythe 59.1%; ICB 60.4%), a scale indicator of 1,165 unreviewed patients of 3,169. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Two-track Core20 neighbourhood outreach

    Average IMD decile is 5.5 and Core20 share is 7.8% (England 21.0%; Folkestone and Hythe 21.7%), but Harbour Medical Practice reaches 77.6% (2,580 estimated patients) with 48.4% good experience (England 76.7%). Moderate effort to run.

    Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.

    Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.

    Option 3

    Pharmacist-led lipid and statin review

    Lipid-lowering therapy for QRISK ≥ 20% is 56.6% (England 63.6%; ICB 61.4%), while statins in diabetes (40+ without CVD) fell 1.7% to 69.2% (England +2.1%, 73.2%). For discussion, pharmacists could recall untreated high-risk and diabetic cohorts alongside a formulary review (£33,129 more than England's unit cost across 97,437 items). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted language and access review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Reconcile Core20 patient outreach lists (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Under-eighty blood pressure review audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Two-track Core20 neighbourhood outreach (p12)Average IMD decile · Core20 cohort (IMD quintile 1) · GPPS good overall experience of the practiceCore20PLUS5 · 10YHP equity test · 10YHP, hospital to communityPCN & Practice
    Option 3 · Pharmacist-led lipid and statin review (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15